Showing results (381-390 of 578) with videos related to
Sort By:
Pageof 58
Journal of Strength and Conditioning Research|April 20, 2016
Assessment of Fatigue and Recovery in Male and Female Athletes After 6 Days of Intensified Strength TrainingChristian Raeder, Thimo Wiewelhove, Rauno Álvaro De Paula Simola, et al.Brain, Behavior, & Immunity - Health|August 13, 2025
Detection of autoantibodies against Interferon Type I in patients with autochthonous West Nile Virus encephalitisJan Braune, Lorenz Pechstein, Christian Meisel, et al.Journal of Electromyography and Kinesiology : Official Journal of the International Society of Electrophysiological Kinesiology|June 19, 2016
Muscle mechanical properties of strength and endurance athletes and changes after one week of intensive trainingRauno Álvaro de Paula Simola, Christian Raeder, Thimo Wiewelhove, et al.Progress in Cardiovascular Diseases|June 5, 2020
Reduced telomere shortening in lifelong trained male football players compared to age-matched inactive controlsMarie Hagman, Christian Werner, Katharina Kamp, et al.Scandinavian Journal of Medicine & Science in Sports|June 20, 2020
Recommendations for initial examination, differential diagnosis, and management of concussion and other head injuries in high-level footballNina Feddermann-Demont, Georges Chiampas, Charlotte M Cowie, et al.Molecular & Cellular Proteomics : MCP|December 19, 2009
Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomesRajaventhan Srirajaskanthan, Martyn E Caplin, Mark G Waugh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Circulating tumor cells as prognostic markers in neuroendocrine tumorsMohid S Khan, Amy Kirkwood, Theodora Tsigani, et al.Nature Reviews. Gastroenterology & Hepatology|January 29, 2021
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinomaJosep M Llovet, Thierry De Baere, Laura Kulik, et al.Molecular Pain|October 29, 2010
Z-360, a novel therapeutic agent for pancreatic cancer, prevents up-regulation of ephrin B1 gene expression and phosphorylation of NR2B via suppression of interleukin-1 β production in a cancer-induced pain model in miceYuki Orikawa, Hiroki Kato, Koichi Seto, et al.Proceedings of the National Academy of Sciences of the United States of America|January 12, 2007
A consensus view of protein dynamicsManuel Rueda, Carles Ferrer-Costa, Tim Meyer, et al.Pageof 58